Diagnosing ventilator-associated pneumonia: the role of bronchoscopy

The Association Between Bronchoscopy and the Prognoses of Patients With Ventilator-Associated Pneumonia in Intensive Care Units: A Retrospective Study Based on the MIMIC-IV Database

Background: In intensive care units (ICUs), the morbidity and mortality of ventilator-associated pneumonia (VAP) are relatively high, and this condition also increases medical expenses for mechanically ventilated patients, which will seriously affect the prognoses of critically ill patients. The purpose of this study was to determine the impact of bronchoscopy on the prognosis of patients with VAP undergoing invasive mechanical ventilation (IMV).

Methods: This was a retrospective study based on patients with VAP from the Medical Information Mart for Intensive Care IV database. The outcomes were ICU and in-hospital mortality. Patients were divided based on whether or not they had undergone bronchoscopy during IMV. Kaplan-Meier (KM) survival curves and Cox proportional-hazards regression models were used to analyze the association between groups and outcomes. Propensity score matching (PSM) and propensity score based inverse probability of treatment weighting (IPTW) were used to further verify the stability of the results. The effect of bronchoscopy on prognosis was further analyzed by causal mediation analysis (CMA).

Results: This study enrolled 1,560 patients with VAP: 1,355 in the no-bronchoscopy group and 205 in the bronchoscopy group. The KM survival curve indicated a significant difference in survival probability between the two groups. The survival probabilities in both the ICU and hospital were significantly higher in the bronchoscopy group than in the no bronchoscopy group. After adjusting all covariates as confounding factors in the Cox model, the HRs (95% CI) for ICU and in-hospital mortality in the bronchoscopy group were 0.33 (0.20–0.55) and 0.40 (0.26–0.60), respectively, indicating that the risks of ICU and in-hospital mortality were 0.67 and 0.60 lower than in the no-bronchoscopy group. The same trend was obtained after using PSM and IPTW. CMA showed that delta-red blood cell distribution width (RDW) mediated 8 and 7% of the beneficial effects of bronchoscopy in ICU mortality and in-hospital mortality.

Conclusion: Bronchoscopy during IMV was associated with reducing the risk of ICU and in-hospital mortality in patients with VAP in ICUs, and this beneficial effect was partially mediated by changes in RDW levels.

Estudo bacteriológico do lavado broncoalveolar na gestão de antibióticos na pneumonia associada à ventilação mecânica de pacientes em unidades de terapia intensiva cirúrgica

OBJETIVO: determinar a correlação da coloração de Gram com o resultado final das culturas de LBA em pacientes cirúrgicos sob ventilação mecânica com PAV clínica. MÉTODOS: Estudo retrospectivo de 252 amostras de lavado broncoalveolar em pacientes com clínica de pneumonia associada à ventilação mecânica com trauma ou cuidados de pós-operatório. As amostras de coloração de Gram foram classificadas como cocos Gram-positivos e bacilos Gram-negativos, todos os outros resultados foram excluídos. Culturas de lavado broncoalveolar foram comparadas aos resultados da coloração de Gram. RESULTADOS: A correlação entre a coloração de Gram e a cultura do lavado broncoalveolar apresentou índice kappa de 0,27. A sensibilidade da coloração de Gram foi 53,9% e a especificidade de 80,6%. Considerando a identificação de cocos Gram-positivos comparada com os outros resultados (negativos e bacilos Gram-negativos), o valor preditivo negativo foi 94,8%. Na avaliação de bacilos Gram-negativos comparada com os outros resultados (negativos e cocos Gram-positivos), a sensibilidade foi 27,1% e a especificidade foi 95,4%. CONCLUSÃO: O valor preditivo negativo para cocos Gram-positivos parece ser aceitável, mas a sensibilidade da coloração de Gram na etiologia de pneumonia associada à ventilação mecânica não permite prever qual é o micro-organismo antes da cultura.

Epidemiology and diagnosis of health care-associated infections in the NICU

Health care-associated infections in the NICU are a major clinical problem resulting in increased morbidity and mortality, prolonged length of hospital stays, and increased medical costs. Neonates are at high risk for health care-associated infections because of impaired host defense mechanisms, limited amounts of protective endogenous flora on skin and mucosal surfaces at time of birth, reduced barrier function of neonatal skin, the use of invasive procedures and devices, and frequent exposure to broad-spectrum antibiotics. This statement will review the epidemiology and diagnosis of health care-associated infections in newborn infants.

Nosocomial pneumonia : rationalizing the approach to empirical therapy

Nosocomial pneumonia or hospital-acquired pneumonia (HAP) causes considerable morbidity and mortality. It is the second most common nosocomial infection and the leading cause of death from hospital-acquired infections. In 1996 the American Thoracic Society (ATS) published guidelines for empirical therapy of HAP. This review focuses on the literature that has appeared since the ATS statement. Early diagnosis of HAP and its etiology is crucial in guiding empirical therapy. Since 1996, it has become clear that differentiating mere colonization from etiologic pathogens infecting the lower respiratory tract is best achieved by employing bronchoalveolar lavage (BAL) or protected specimen brush (PSB) in combination with quantitative culture and detection of intracellular microorganisms. Endotracheal aspirate and non-bronchoscopic BAL/PSB in combination with quantitative culture provide a good alternative in patients suspected of ventilator-associated pneumonia. Since culture results take 2-3 days, initial therapy of HAP is by definition empirical. Epidemiologic studies have identified the most frequently involved pathogens: Enterobacteriaceae, Haemophilus influenzae, Streptococcus pneumoniae and Staphylococcus aureus ('core pathogens'). Empirical therapy covering only the 'core pathogens' will suffice in patients without risk factors for resistant microorganisms. Studies that have appeared since the ATS statement issued in 1996, demonstrate several new risk factors for HAP with multiresistant pathogens. In patients with risk factors, empirical therapy should consist of antibacterials with a broader spectrum. The most important risk factors for resistant microorganisms are late onset of HAP (>/=5 days after admission), recent use of antibacterial therapy, and mechanical ventilation. Multiresistant bacteria of specific interest are methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Acinetobacter calcoaceticus-baumannii, Stenotrophomonas maltophilia and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. Each of these organisms has its specific susceptibility pattern, demanding appropriate antibacterial treatment. To further improve outcomes, specific therapeutic options for multiresistant pathogens and pharmacological factors are discussed. Antibacterials developed since 1996 or antibacterials with renewed interest (linezolid, quinupristin/dalfopristin, teicoplanin, meropenem, new fluoroquinolones, and fourth-generation cephalosporins) are discussed in the light of developing resistance.Since the ATS statement, many reports have shown increasing incidences of resistant microorganisms. Therefore, one of the most important conclusions from this review is that empirical therapy for HAP should not be based on general guidelines alone, but that local epidemiology should be taken into account and used in the formulation of local guidelines.

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review

BACKGROUND

Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in critically ill patients. The clinical and economic consequences of VAP are unclear, with a broad range of values reported in the literature

OBJECTIVE

To perform a systematic review to determine the incidence of VAP and its attributable mortality rate, length of stay, and costs.

DATA SOURCE

Computerized PUBMED and MEDLINE search supplemented by manual searches for relevant articles, limited to articles published after 1990.

STUDY SELECTION

English-language observational studies and randomized trials that provided data on the incidence of VAP were included. Matched cohort studies were included for calculation of attributable mortality rate and length of stay.

DATA EXTRACTION

Data were extracted on patient population, diagnostic criteria for VAP, incidence, outcome, type of intensive care unit, and study design.

DATA SYNTHESIS

The cumulative incidence of VAP was calculated by combining the results of several studies using standard formulas for combining proportions, in which the weighted average and variance are calculated. Results from studies comparing intensive care unit and hospital mortality due to VAP, additional length of stay, and additional days of mechanical ventilation were pooled using a random effects model, with assessment of heterogeneity.

RESULTS

Our findings indicate a) between 10% and 20% of patients receiving >48 hrs of mechanical ventilation will develop VAP; b) critically ill patients who develop VAP appear to be twice as likely to die compared with similar patients without VAP (pooled odds ratio, 2.03; 95% confidence interval, 1.16-3.56); c) patients with VAP have significantly longer intensive care unit lengths of stay (mean = 6.10 days; 95% confidence interval, 5.32-6.87 days); and d) patients who develop VAP incur > or = USD $10,019 in additional hospital costs.

CONCLUSIONS

Ventilator-associated pneumonia occurs in a considerable proportion of patients undergoing mechanical ventilation and is associated with substantial morbidity, a two-fold mortality rate, and excess cost. Given these findings, strategies that effectively prevent VAP are urgently needed.

Role of bronchoscopy in modern medical intensive care unit

This article gives a broad overview of the increasingly important applications of bronchoscopy, flexible (FOB) and rigid (RB), in a modern medical intensive care unit. Special emphasis is made to bronchoscopy use in mechanically ventilated patients. Therapies such as endobronchial stenting and Nd:YAG laser are being used to improve respiratory failure and facilitate weaning from mechanical ventilation. Practical applications of recent advancements in technology (endobronchial stenting, laser therapy, and so forth), the increasing use of rigid bronchoscopy, and the new generation of flexible bronchoscopes like battery bronchoscopes, and ultra-thin bronchoscopes, are also discussed. The risks, potential benefits, complications, and suggested technique of performing bronchoscopy in mechanically ventilated patients are reviewed.

Fiberoptic bronchoscopy in coronary care unit patients: indications, safety, and clinical implications

STUDY OBJECTIVES

To evaluate the indications, safety, therapeutic impact, and outcome of fiberoptic bronchoscopy (FOB) in coronary care unit (CCU) patients.

DESIGN

Retrospective review of all CCU patients undergoing FOB during a 6-year period.

SETTING

Tertiary care university hospital.

RESULTS

Among 8,330 patients admitted to the CCU; 40 (0.5%) patients underwent FOB to evaluate pulmonary abnormalities, most often (78%) to appraise clinically suspected pneumonia. Thirty-five (88%) patients were intubated and 21 (53%) had acute myocardial infarction (MI) before FOB. There were two major complications (bleeding, intubation) occurring within 24 h of FOB, one of which appeared due to the procedure. No episodes of chest pain or ischemic events were recorded and no significant increase in major complications was noted in MI patients (3% vs 5%). Patients having FOB within 10 days of MI had higher survival (79%) than those undergoing FOB later (29%) (p = 0.05). Seven different bacterial pathogens were isolated in 6 (15%) patients, probably reflecting prior empiric antibiotics in 32 (80%) patients. Therapy was changed in 64% of patients in whom a potential pathogen was identified. Despite alterations in treatment, patients with clinically suspected pneumonia and any organisms isolated by FOB had greater mortality (79% vs 31%, p = 0.003) than those with sterile FOB cultures.

CONCLUSION

FOB may be diagnostically useful in the evaluation of pulmonary abnormalities in selected patients with acute cardiac disease, can be performed safely, and may influence management decisions. Positive bronchoscopy cultures often influence therapy but are associated with higher mortality, suggesting a lethal effect of nosocomial pneumonia in this subset of CCU patients. The risks of FOB must be weighed with the impact of FOB results on patient outcome, and its role requires further investigation.

Phagocytic activity of bronchoalveolar lavage neutrophils in intensive care unit patients on mechanical ventilation

In ventilator-dependent patients the management of clinically suspected nosocomial pneumonia is often difficult. A diagnosis of pneumonia is based upon findings including pulmonary infiltrate, fever, leukocytosis, or purulent secretions. By using bronchoscopic techniques, we can obtain bronchoalveolar lavage specimens (BAL) from the affected area of the lung. Neutrophils (PMN), which are important for lung defense, are found in increased numbers in BAL of these patients. We therefore ascertained the phagocytic activity of PMN against bacteria and fungi by microscopic examination. BAL specimens from ten mechanically ventilated patients were evaluated to assess the cellular counts using a Bürker hemocytometer, the differential cell counts by cytospin preparations (MGG stain), and the phagocytic activity of PMN and macrophages using the intracellular bacteria index (ICB) values. Microscopical examination of BAL cells and evaluation of ICB values (cut-off > 5%) were higher in four out of twelve patients and the quantitative assessment of bacteria in PMN cytoplasm on cytospin preparations was found to be useful for the diagnosis of pneumonia. In these patients, pneumonia was suspected (in one patient fungal pneumonia) on the basis of microscopical examination of BAL cells and ICB values and the findings were confirmed later by microbiological cultures. In conclusion, in patients on mechanical ventilation a rapid diagnosis of bacterial or fungal pneumonia can be made using BAL cytology and by ICB values, and this in turn allows appropriate therapy to be initiated at an early stage. However, further studies of neutrophil functions are required to improve our understanding of the increased incidence of pulmonary infections in these patients.